We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI Model Could Help Diagnose Spinal Cord Disease Up To 30 Months Earlier

By HospiMedica International staff writers
Posted on 26 Feb 2026

Cervical spondylotic myelopathy (CSM) is the leading cause of spinal cord dysfunction in older adults and occurs when arthritis in the neck compresses the spinal cord. More...

The condition is chronic and progressive, often causing neck pain, muscle weakness, walking difficulties and other disabling symptoms. Diagnosis can take years because early signs are frequently overlooked, and by the time it is recognized, treatment options may be limited. Researchers have now developed an artificial intelligence (AI)-based method that can identify individuals at risk of CSM up to 30 months before clinical diagnosis, potentially enabling earlier intervention and improved outcomes.

A multidisciplinary team of surgeon-scientists and computer scientists at Washington University in St. Louis (WashU, St. Louis, MO, USA) created and evaluated seven different AI models to analyze electronic health record data from more than two million individuals with and without CSM. The models examined patterns of health care interactions, including diagnostic tests and recorded conditions, to identify patients whose medical histories resemble those already diagnosed with CSM. Both large foundation models pretrained on extensive clinical datasets and smaller, clinically informed models focusing on relevant variables, were trained and tested to predict risk well before formal diagnosis.

The models were trained using a large external dataset and a smaller dataset from a St. Louis–based health system to assess prediction accuracy across different time horizons. The foundation models performed best during internal validation on a large, heterogeneous dataset, while the smaller, clinically derived model demonstrated stronger generalizability and more consistent results across external systems. Two mid-scale models underperformed across the evaluated time points. The findings, published in npj Digital Medicine, show that risk for CSM can be predicted as early as 30 months before a clinical diagnosis, with simpler models incorporating clinical insight achieving comparable or superior performance.

Earlier identification of CSM risk could allow clinicians to intervene at a stage when treatment may prevent further neurological decline. By screening electronic health records for subtle warning patterns, the AI system may help flag patients who would otherwise remain undiagnosed until advanced stages. The researchers suggest that combining deep learning with established clinical knowledge may improve AI applications across health care. Future work will focus on refining the models and evaluating their integration into real-world clinical workflows.

“We were able to achieve at least comparable, if not superior performance with a much, much simpler model by focusing on existing clinical knowledge while still using a deep learning model,” said Assistant Professor Jacob Greenberg, MD, co-senior author of the study. “AI clearly has emerging opportunities in medicine, but we often focus only on the areas where purely data-driven solutions excel. There’s still an important role for clinical knowledge, which is going to be true for a lot of applications in health care.”

Related Links:
WashU


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.